Job Research Foundation Announces 2024 Grant Recipient

2024-03-12
临床研究免疫疗法
NEW YORK, March 12, 2024 /PRNewswire/ -- The Job Research Foundation was established to underwrite research into Job Syndrome, also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), a rare multisystem immunodeficiency disorder. The Foundation's main goal is to help advance research to improve treatments for patients suffering from the disease and eventually find a cure for Job Syndrome.
Continue Reading
Job Research Foundation Announces 2024 Grant Recipient
Preview
来源: PRNewswire
Job Research Foundation funds research into the causes and possible treatments for the disease.
This year's recipient,
Dr. Rasmus O. Bak, Associate Professor at Aarhus University in Denmark, will receive a grant totaling $200,000. The title of his research project is Next Generation CRISPR/Cas-based ex vivo Gene Editing of Autologous Hematopoietic Stem Cells as a Curative Treatment of Job Syndrome.
Since 2019 the Job Research Foundation has funded a total of 15 scientific research projects. The scientists hail from Australia, Germany, Spain, the US, the UK, and Denmark. Additionally, the researchers are from prestigious institutions including the Garvan Institute, Helmholtz Zentrum München, Hospital Infantil Universitario, Rockefeller University, Massachusetts General/Harvard Medical School, University of Newcastle, University of Pennsylvania, Boston Children's Hospital, University of Freiburg, Columbia University, and the DHHS/NIH. A list of the researchers and their projects can be viewed here https://www.jobresearchfoundation.org/grant-recipients.
The Job Research Foundation will start accepting the next round of grant applications in July 2024. Applications can be found on the website here: https://www.jobresearchfoundation.org/grant-application-process
Job Syndrome was discovered in 1966 and is found in males and females worldwide. Visit https://www.jobresearchfoundation.org/ for additional information.
Media Contact:
Risa B. Hoag, GMG PR, 845-627-3000,
[email protected]
SOURCE Job Research Foundation
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。